These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 28068865)
21. Homocysteine and cardiovascular disease: a review of the evidence. Wierzbicki AS Diab Vasc Dis Res; 2007 Jun; 4(2):143-50. PubMed ID: 17654449 [TBL] [Abstract][Full Text] [Related]
22. Homocysteine as a predictor of cognitive decline in Alzheimer's disease. Oulhaj A; Refsum H; Beaumont H; Williams J; King E; Jacoby R; Smith AD Int J Geriatr Psychiatry; 2010 Jan; 25(1):82-90. PubMed ID: 19484711 [TBL] [Abstract][Full Text] [Related]
23. Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? Galimberti G; Conti E; Zini M; Piazza F; Fenaroli F; Isella V; Facheris M; Perlangeli V; Antolini L; DeFilippi F; Ferrarese C Clin Biochem; 2008 Jul; 41(10-11):914-6. PubMed ID: 18439912 [TBL] [Abstract][Full Text] [Related]
24. Homocysteine is not so paradoxical. Klevay LM Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):e160; author reply e161. PubMed ID: 18799792 [No Abstract] [Full Text] [Related]
25. [Risk factors for cardiovascular diseases: what is the role for homocysteine?]. Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357 [TBL] [Abstract][Full Text] [Related]
27. The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease? Abraham JM; Cho L Cleve Clin J Med; 2010 Dec; 77(12):911-8. PubMed ID: 21147945 [TBL] [Abstract][Full Text] [Related]
28. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. de Jager CA; Oulhaj A; Jacoby R; Refsum H; Smith AD Int J Geriatr Psychiatry; 2012 Jun; 27(6):592-600. PubMed ID: 21780182 [TBL] [Abstract][Full Text] [Related]
30. Critical levels of brain atrophy associated with homocysteine and cognitive decline. de Jager CA Neurobiol Aging; 2014 Sep; 35 Suppl 2():S35-9. PubMed ID: 24927906 [TBL] [Abstract][Full Text] [Related]
31. A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people. Kwok T; Lee J; Law CB; Pan PC; Yung CY; Choi KC; Lam LC Clin Nutr; 2011 Jun; 30(3):297-302. PubMed ID: 21216507 [TBL] [Abstract][Full Text] [Related]
32. Cognitive Status According to Homocysteine and B-Group Vitamins in Elderly Adults. Bonetti F; Brombo G; Magon S; Zuliani G J Am Geriatr Soc; 2015 Jun; 63(6):1158-63. PubMed ID: 26031567 [TBL] [Abstract][Full Text] [Related]
34. Low and high homocysteine are associated with mortality independent of B group vitamins but interactive with cognitive status in a free-living elderly cohort. Xiu LL; Lee MS; Wahlqvist ML; Chen RC; Huang YC; Chen KJ; Li D Nutr Res; 2012 Dec; 32(12):928-39. PubMed ID: 23244538 [TBL] [Abstract][Full Text] [Related]
35. [Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?]. Méndez-González J; Rodríguez-Millán E; Julve J; Blanco-Vaca F Rev Neurol; 2010 Feb 16-28; 50(4):235-44. PubMed ID: 20198596 [TBL] [Abstract][Full Text] [Related]
36. Homocysteine, B vitamins, and the risk of cardiovascular disease. Clarke R Clin Chem; 2011 Aug; 57(8):1201-2. PubMed ID: 21666070 [No Abstract] [Full Text] [Related]
37. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Clarke R; Armitage J Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852 [TBL] [Abstract][Full Text] [Related]
40. A controlled trial of homocysteine lowering and cognitive performance. McMahon JA; Green TJ; Skeaff CM; Knight RG; Mann JI; Williams SM N Engl J Med; 2006 Jun; 354(26):2764-72. PubMed ID: 16807413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]